Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 10;11(6):1179-88.
doi: 10.5114/aoms.2015.56343. Epub 2015 Dec 11.

Pulmonary manifestations of inflammatory bowel disease

Affiliations

Pulmonary manifestations of inflammatory bowel disease

Sebastian Majewski et al. Arch Med Sci. .

Abstract

Bronchopulmonary signs and symptoms are examples of variable extraintestinal manifestations of the inflammatory bowel diseases (IBD). These complications of Crohn's disease (CD) and ulcerative colitis (UC) seem to be underrecognized by both pulmonary physicians and gastroenterologists. The objective of the present review was to gather and summarize information on this particular matter, on the basis of available up-to-date literature. Tracheobronchial involvement is the most prevalent respiratory presentation, whereas IBD-related interstitial lung disease is less frequent. Latent and asymptomatic pulmonary involvement is not unusual. Differential diagnosis should always consider infections (mainly tuberculosis) and drug-induced lung pathology. The common link between intestinal disease and lung pathology is unknown, but many hypotheses have been proposed. It is speculated that environmental pollution, common immunological mechanisms and predisposing genetic factors may play a role.

Keywords: Crohn's disease; inflammatory bowel disease; interstitial lung disease; tracheobronchitis; ulcerative colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chest X-ray of a 19-year-old woman with long standing CD treated with mesalazine. Pulmonary infiltrations and right sided pleural effusion are visible. Due to the presence of fever, dry cough and pleural chest pain, pleuropneumonia was diagnosed and antibiotics were introduced. Because of lack of response to antimicrobial treatment she was referred to a pulmonary physician, who recommended withdrawal of mesalazine. After initial improvement, the general and radiological symptoms relapsed (see Figure 2), suggesting the possibility of IBD-related pathology
Figure 2
Figure 2
Computed tomography of the same patient performed a few weeks after the presented chest X-ray (Figure 1). Subpleural nodes and nodules are visible. Video-assisted thoracoscopic examination was performed and lung biopsy revealed organizing pneumonia. Clinical and radiological symptoms responded very well to oral steroids and did not relapse until renewed introduction of mesalazine
Figure 3
Figure 3
Chest X-ray of a young woman treated for CD with infliximab, showing consolidation in the left lower lobe (A) and a CT scan showing bilateral opacities predominantly in the left basal segments (B). She presented with productive cough and fever, non-responsive to empirical antibiotic treatment. The radiological picture and clinical context suggested IBD-related lung disease. Transbronchial lung biopsy was non-diagnostic and the patient refused surgical biopsy. Steroids were introduced but were withdrawn shortly after the bronchoalveolar aspirate appeared positive for Mycobacterium tuberculosis. Note the atypical location of TB lung infiltrations

References

    1. Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237–47. - PMC - PubMed
    1. Yamamoto-Furusho JK. Genetic factors associated with the development of inflammatory bowel disease. World J Gastroenterol. 2007;13:5594–7. - PMC - PubMed
    1. Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012;72:2333–49. - PubMed
    1. Rankin GB, Watts HD, Melnyk CS, et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914–20. - PubMed
    1. Mendoza JL, Lana R, Taxonera C, et al. Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis. Med Clin (Barc) 2005;125:297–300. - PubMed

LinkOut - more resources